Logo

Judith Wolf, Donald Munroe, Daniel Chan, Robert Bristow, Calaneet Balas

Nov 19, 2014

Vermillion has formed a strategic and medical advisory board that it said will be led by Chief Medical Officer Judith Wolf and Chief Science Officer Donald Munroe.

The company named as charter members of the board Daniel Chan; director of Johns Hopkins University School of Medicine's Center for Biomarker Discovery and Translation; Robert Bristow, director of gynecologic oncology and vice-chair for clinical affairs and quality improvement at the University of California, Irvine; and Calaneet Balas, CEO of the Ovarian Cancer National Alliance.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.